GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Cash Receipts from Securities Related Activities

Arovella Therapeutics (FRA:E4NA) Cash Receipts from Securities Related Activities


View and export this data going back to 2021. Start your Free Trial

What is Arovella Therapeutics Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applies to banks.


Arovella Therapeutics (FRA:E4NA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (FRA:E4NA) » Definitions » Cash Receipts from Securities Related Activities
Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton, WA, AUS, 3053
Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.